Showing 217–240 of 479 results
-
HEMO
Immunohematology Anti-B titration – Hemotherapy
Identificação de Anticorpos Irregulares – IAI
EPCIMRCCAMR -
HEMO
Immunohematology Automation – Hemotherapy
ABO and Rhesus System – Rh (D) Extravascular Antibody Survey – PAI (Indirect Coombs) Research of Intravascular Antibodies – TAD (Direct Coombs)
EPCIMRCCAMR -
HEMO
Immunohematology Elution – Hemotherapy
Direct Coombs Conclusion Elution IAI identification
EPCIMRCCAMR -
CL
Immunohematology Phenotyping RH and Kell
Antigens D, C, c, E, e, Cw, K, k, Kpa, Kpb RH system genotypes
EPCIMRCCAMR -
HEMO
Immunohematology Phenotyping RH and Kell – Hemotherapy
Antigens D, C, c, E, e, Cw, K, k, Kpa, Kpb RH system genotypes
EPCIMRCCAMR -
HEMO
Immunohematology TAD – Hemotherapy
Intravascular antibody test – TAD (Coombs Direct)
EPCIMRCCAMR -
CL
Immunosuppressant Drugs
Immunosuppressive Drugs I Azathioprine Cyclosporine Everolimus Sirolimus (rapamycin) Tacrolimus Immunosuppressive Drugs II Mycophenolic Acid Dexamethasone
EPCIMRCCAMR -
CL
Influenza A and B – Molecular Biology
The program includes PCR-based molecular testing. Detection of Influenza A and B.
EPCIMRCCAMR -
CL
Janus kinase 2 (JAK-2) – Mutation Screening
The program includes PCR-based molecular testing. JAK-2 gene V617F mutation research. Related tests Myeloproliferative Diseases JAK2 gene V617F gene Janus Kinase 2 Polycythemia Vera
EPCIMRCCAMR -
CL
Klebsiella – Molecular Biology
The program includes PCR-based molecular testing. The samples contain the complete genome of the microorganism. Detection by Molecular Biology of: Klebsiella sp. Klebsiella pneumoniae Klebsiella oxytoca
EPCIMRCCAMR














